Precipio, Inc. (PRPO)
$22.59-2.29%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $40M
- Beta
- 1.33
- P/E (TTM)
- -36.08
- Short % float
- 4.89%
- Days to cover
- 1.0
- SI change
- -7.0%
- 1W
- -5.88%
- 1M
- -17.31%
- vs SPY 1W
- -6.30%
- vs SPY 1M
- -19.37%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 3
- GROWTH
- 37
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-5.1%
REV YoY-
ROE-8.5%
EPS YoY-
ROA-5.7%
GROSS44
OP-6
NET-4
[VALUATION]
P/E TTM-36.08
P/E FWD-
SECTOR PE20.54
INDUSTRY PE31.57
P/B2.84
P/FCF-
EV/EBITDA171.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E22.60
ALTMAN Z-
CURR RATIO1.77
ND/EBITDA-
BETA1.33
Company news
FAQ
- What is LOPJLB’s current signal on PRPO?
- LOPJLB’s latest quantitative signal on Precipio, Inc. (PRPO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PRPO in?
- Precipio, Inc. (PRPO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Precipio, Inc. (PRPO) do?
- Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell linea…